Consejo Nacional de Salud

nih.gov/pubmed/18713048?ordinalpos=
3&itool=EntrezSystem2.PEntrez.Pubmed.
Pubmed_ResultsPanel.Pubmed_Default-
ReportPanel.Pubmed_RVDocSum, PMID:
18713048, [consulta 13 de noviembre
2008]
52 Mohr Jf, Update on the efficacy and tolerability
of meropenem in the treatment of serious
bacterial infections, {en línea}, University
of Texas Health Science Center, Houston,
Texas, Septiembre 15 2008, disponible en
www: http://www.ncbi.nlm.nih.gov/pub
med/18713049?ordinalpos=47&itool=Ent
rezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.
Pubmed_RVDocSum, PMID: 18713049,
[consulta 14 de noviembre 2008]
53 Samuel M, Ti TY. Interventions for treating
melioidosis. Cochrane Database of Systematic
Reviews 2002, Issue 4. Art. No.:
CD001263. DOI: 10.1002/14651858.
CD001263.
54 Choi Jy, Kim Co, Park Ys, Yoon Hj, Shin Sy,
Kim Yk, Kim Ms, Kim Ya, Ssong Yg, Yong
D, Lee K, Kim Jm, Comparison of efficacy
of cefoperazone/sulbactam and imipenem/
cilastatin for treatment of Acinetobacter bacteremia,
{en línea}, Department of Internal
Medicine, Yonsei University College of Medicine,
Seodaemun-gu, Seoul 120-752, Korea,
disponible en www: http://www.ncbi.nlm.
nih.gov/pubmed/16502486?ordinalpos=
1&itool=EntrezSystem2.PEntrez.Pubmed.
Pubmed_ResultsPanel.Pubmed_Discovery-
Panel.Pubmed_Discovery_RA&linkpos=3&
log$=relatedarticles&logdbfrom=pubmed,
PMID: 16502486, [consulta 10 de noviembre
2008]
55 Schmitt Dv, Leitner E, Wwlte T, Lode H,
Piperacillin/tazobactam vs imipenem/
cilastatin in the treatment of nosocomial
pneumonia--a double blind prospective multicentre
study,{en línea}, Universitätsklini-
kum, Herzzentrum Leipzig, Herzchirurgie,
Russenstrasse 19, 04289 Leipzig, Germany,
disponible en www: http://www.ncbi.nlm.
nih.gov/pubmed/16804655?ordinalpos=
60&itool=EntrezSystem2.PEntrez.Pubmed.
Pubmed_ResultsPanel.Pubmed_Default-
ReportPanel.Pubmed_RVDocSum, PMID:
16804655, [consulta 10 de noviembre
2008]
56 Lin D, Li WK, Rieder MJ. Cotrimoxazole
for prophylaxis or treatment of opportunistic
infections of HIV/AIDS in patients
with previous history of hypersensitivity to
cotrimoxazole. Cochrane Database of Systematic
Reviews 2007, Issue 2. Art. No.:
CD005646. DOI: 10.1002/14651858.
CD005646.pub2.
57 Leonard Sn, Kaatz Gw, Rucker Lr, Rybak
Mj, Synergy between gemifloxacin and
trimethoprim/sulfamethoxazole against
community-associated methicillin-resistant
Staphylococcus aureus, {en línea},Anti-
Infective Research Laboratory, Eugene Applebaum
College of Pharmacy and Health
Sciences, Wayne State University, 259
Mack Avenue, Detroit, MI 48201, USA, 18
de Septiembre 2008, disponible en www:
http://www.ncbi.nlm.nih.gov/pubmed/1
8801920?ordinalpos=23&itool=EntrezSyst
em2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_
RVDocSum, PMID: 18801920, [consulta
12 de noviembre 2008]
58 Green H, Paul M, Vidal L, Leibovici L. Prophylaxis
for Pneumocystis pneumonia (PCP)
in non-HIV immunocompromised patients.
Cochrane Database of Systematic Reviews
2007, Issue 3. Art. No.: CD005590. DOI:
10.1002/14651858.CD005590.pub2
59 Williams GJ, Wei L, Lee A, Craig JC. Longterm
antibiotics for preventing recurrent
urinary tract infection in children. Cochrane
Database of Systematic Reviews
GRUPO J | Antiinfecciosos para uso sistémico
319
J